Skip to content
Aperlena

Germany - Medicines - Biosimilar medicine awards 01.07.2026

Original Deutschland - Arzneimittel - Arzneimittelvergaben Biosimilare 01.07.2026

Open Contract notice No deadline published
Watch this tender

We email you if the deadline moves or a correction is published. Free. Log in

The Aperlena Verdict

Open race

No supplier dominates: 108 different companies have won the last 294 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Based on 294 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

A German buyer intends to award contracts for the delivery of medicines and pharmacy-standard goods. The procurement covers biosimilar medicines: Aflibercept 2 mg injection solution in vials and pre-filled syringes, and Denosumab in several presentations, including 120 mg in 1 ml and 1.7 ml vials and 60 mg and 120 mg pre-filled syringes. Contracts are intended to start on 01.07.2026, with the contract duration still to be determined.

Description

Absicht zum Abschluss von Verträgen zur Lieferung von Arzneimitteln und apothekenüblichen Waren. Beschaffung des Arzneimittels 'Aflibercept 2 mg Injektionslösung Durchstechflasche St' für einen beabsichtigten Vertragsstart am 01.07.2026 und einen noch festzulegenden Zeitraum.; Beschaffung des Arzneimittels 'Aflibercept 2 mg Injektionslösung Fertigspritze St' für einen beabsichtigten Vertragsstart am 01.07.2026 und einen noch festzulegenden Zeitraum.; Beschaffung des Arzneimittels 'Denosumab 120 mg in 1 ml Lsg. Injektionslösung Fertigspritze St' für einen beabsichtigten Vertragsstart am 01.07.2026 und einen noch festzulegenden Zeitraum.; Beschaffung des Arzneimittels 'Denosumab 120 mg in 1.7 ml Lsg. Injektionslösung Durchstechflasche St' für einen beabsichtigten Vertragsstart am 01.07.2026 und einen noch festzulegenden Zeitraum.; Beschaffung des Arzneimittels 'Denosumab 60 mg in 1 ml Lsg. Fertigspritzen St' für einen beabsichtigten Vertragsstart am 01.07.2026 und einen noch festzulegenden Zeitraum.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

More from this buyer

Full buyer profile

6 open tenders right now

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
ASTRAZENECA GMBH 11 n/a Jul 2026
Bayer Vital GmbH 8 n/a Sep 2026
Pfizer Pharma GmbH 8 n/a Mar 2026
Amgen GmbH 7 n/a Mar 2026
CC-Pharma GmbH 7 n/a Mar 2026

Based on 294 awards with a linked company profile over the last 5 years.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,028,743
9,662 open across Europe right now
Buyer track record on Aperlena
311 notices tracked · 305 awarded

Never miss a tender like this

69 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close